MARATTO

article · OALib

Hypovitaminosis E and Endometriosis in a Sub-Saharan Population

Abstract

Endometriosis is a chronic gynecological condition defined by the presence of endometrial-like tissue outside the uterus affecting approximately one in 10 women worldwide. Endometriosis is source of chronic pelvic pain and infertility and represents a significant economic burden. This study aims to determine the frequency of hypovitaminosis E in sub-Saharan women in Kinshasa with endometriosis and identify associated risk factors. A casecontrol study of 244 patients undergoing a laparoscopy in 8 Kinshasa medical centers between January 2019 and October 2022. Among these, 82 women with endometriosis (cases) and 164 women with a normal pelvis (controls) were matched in age function. Chi-square tests and t-tests were used to compare these two groups. A multivariate logistic regression was performed to identify risk factors related to endometriosis. Hypovitaminosis E in women with endometriosis was 74.39%. Dysmenorrhea (OR 24.234 [95% CI: 12.141 -50.026)], p < 0.001), nulliparity (OR 5.157 [95% CI: 2.458 -10.819], p < 0.001), history of unsafe abortion , p < 0.001), infertility (OR 5.157 [95% CI: 2.458 -10.819], p = 0.02), early menarche , p < 0.001) and hypovitaminosis E (OR 4.538 [95% CI: 2.523 -8.161], p < 0.001 were identified as risk factors. Use of oral contraceptives (OR 0.188 [95% CI: 0.093 -0.381], p < 0.001) had a protective factor against endometriosis. Despite some limits, our data underline the role of vitamin E deficiency as a potential factor of endometriosis in a

Research topics

  • Endometriosis Research and Treatment
  • Vitamin D Research Studies

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.4236/oalib.1110485

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.